Livent Corporation manufactures and sells performance lithium compounds for energy storage, specialty polymer, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific.
Excellent balance sheet with limited growth.
Share Price & News
How has Livent's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: LTHM's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: LTHM underperformed the US Chemicals industry which returned -6% over the past year.
Return vs Market: LTHM underperformed the US Market which returned 19.4% over the past year.
Price Volatility Vs. Market
How volatile is Livent's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StA Rising Share Price Has Us Looking Closely At Livent Corporation's (NYSE:LTHM) P/E Ratio
4 weeks ago | Simply Wall StIf You Had Bought Livent (NYSE:LTHM) Stock A Year Ago, You'd Be Sitting On A 31% Loss, Today
1 month ago | Simply Wall StAre Livent's (NYSE:LTHM) Statutory Earnings A Good Guide To Its Underlying Profitability?
Is Livent undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate LTHM's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate LTHM's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: LTHM is good value based on its PE Ratio (21.3x) compared to the Chemicals industry average (22.4x).
PE vs Market: LTHM is poor value based on its PE Ratio (21.3x) compared to the US market (18.3x).
Price to Earnings Growth Ratio
PEG Ratio: LTHM is poor value based on its PEG Ratio (3.8x)
Price to Book Ratio
PB vs Industry: LTHM is overvalued based on its PB Ratio (3x) compared to the US Chemicals industry average (2.1x).
How is Livent forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LTHM's forecast earnings growth (5.6% per year) is above the savings rate (1.7%).
Earnings vs Market: LTHM's earnings (5.6% per year) are forecast to grow slower than the US market (14.2% per year).
High Growth Earnings: LTHM's earnings are forecast to grow, but not significantly.
Revenue vs Market: LTHM's revenue (11.4% per year) is forecast to grow faster than the US market (7.6% per year).
High Growth Revenue: LTHM's revenue (11.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LTHM's Return on Equity is forecast to be low in 3 years time (11.6%).
How has Livent performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: LTHM has a high level of non-cash earnings.
Growing Profit Margin: LTHM's current net profit margins (17.8%) are lower than last year (20.5%).
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if LTHM's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: LTHM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: LTHM had negative earnings growth (-14.6%) over the past year, making it difficult to compare to the Chemicals industry average (-15.9%).
Return on Equity
High ROE: LTHM's Return on Equity (14.1%) is considered low.
Return on Assets
Return on Capital Employed
How is Livent's financial position?
Financial Position Analysis
Short Term Liabilities: LTHM's short term assets ($253.6M) exceed its short term liabilities ($90.0M).
Long Term Liabilities: LTHM's short term assets ($253.6M) exceed its long term liabilities ($124.9M).
Debt to Equity History and Analysis
Debt Level: LTHM's debt to equity ratio (16.6%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if LTHM's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: LTHM's debt is well covered by operating cash flow (104.8%).
Interest Coverage: LTHM's interest payments on its debt are well covered by EBIT (346x coverage).
Inventory Level: LTHM has a high level of physical assets or inventory.
Debt Coverage by Assets: LTHM's debt is covered by short term assets (assets are 2.8x debt).
What is Livent's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate LTHM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate LTHM's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if LTHM's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if LTHM's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of LTHM's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Paul Graves (47yo)
Mr. Paul W. Graves has been President, Chief Executive Officer & Director of Livent Corporation since May 2018. Mr. Graves was Chief Executive Officer of Planned FMC Lithium Company since May 2018 until 20 ...
CEO Compensation Analysis
Compensation vs Market: Paul's total compensation ($USD5.61M) is above average for companies of similar size in the US market ($USD3.81M).
Compensation vs Earnings: Paul's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
|VP & CFO||1.8yrs||US$1.49m||0.0048% $78.5k|
|Global Head of Manufacturing & Operations||1.1yrs||no data||no data|
|Corporate Controller & Chief Accounting Officer||0.9yrs||no data||no data|
|Investor Relations Manager||0yrs||no data||no data|
|VP, General Counsel & Secretary||1.8yrs||no data||no data|
|Chief Communications Officer & Global Head of Public Affairs||0yrs||no data||no data|
|Chief Human Resources Officer||0yrs||no data||no data|
|Chief Commercial Officer||0yrs||no data||no data|
Experienced Management: LTHM's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
|Independent Director||2.1yrs||US$69.70k||0.097% $1.6m|
|Independent Director||2.1yrs||US$73.89k||0.026% $417.0k|
|Chairman||1.3yrs||no data||0.19% $3.1m|
|Director||1.3yrs||no data||0.072% $1.2m|
|Independent Director||2.1yrs||US$71.10k||0.034% $557.6k|
|Director||0yrs||no data||0.0064% $104.6k|
|Director||0yrs||no data||0.0016% $26.7k|
|Independent Director||2.1yrs||US$69.70k||0.0082% $133.0k|
Experienced Board: LTHM's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.1%.
Livent Corporation's company bio, employee growth, exchange listings and data sources
- Name: Livent Corporation
- Ticker: LTHM
- Exchange: NYSE
- Founded: 2018
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: US$1.626b
- Shares outstanding: 145.98m
- Website: https://www.livent.com
Number of Employees
- Livent Corporation
- 2929 Walnut Street
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|LTHM||NYSE (New York Stock Exchange)||Yes||Common Stock||US||USD||Oct 2018|
|8LV||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Oct 2018|
Livent Corporation manufactures and sells performance lithium compounds for energy storage, specialty polymer, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics, as well as lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania. Livent Corporation operates independently of FMC Corporation as of March 1, 2019.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/19 02:51|
|End of Day Share Price||2020/02/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.